Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation
NCT ID: NCT04595448
Last Updated: 2023-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2020-09-15
2022-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will use t2 weighted MRI, Near-infrared fluorescence imaging, and plethysmography to examine the above-mentioned question.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function
NCT00661323
Exercise Stress MRI to Evaluate Aortic Function (Compliance, Distensibility, Pulse Wave Velocity) and Left Ventricular Function : Validation in Healthy Volunteers and in Selected Patients. A Pilot Study.
NCT02018835
3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation
NCT04442828
Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment
NCT03572998
Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure
NCT05573997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will be examined at one occasion using t2-weighted MRIs to evaluated lymphatic anatomy and Near-infrared fluorescence imaging for evaluation of superficial peripheral lymphatic function. Finally, the capillary filtration rate will be estimated using plethysmography.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients suffering from moderate tricuspid valve regurgitation
No interventions assigned to this group
Controls
Cardiovascular healthy, age, gender and weight matched controls.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
* Informed consent
* Healthy
* Age ≥18 years
* Age, gender and weight matched with included patients.
Exclusion Criteria
* Congenital heart disease
* Left sided valve disease
* MRI contraindications (All metal implants, cochlear implants, pacemakers etc.)
* Claustrophobia
* Peripheral edema
* BMI\>30
* Age\<18.
Controls:
* Cardiovascular disease
* MRI contraindications (All metal implants, cochlear implants, pacemakers etc.)
* Claustrophobia
* Peripheral edema
* BMI\>30
* Age\<18.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiothoracic Surgery
Aarhus N, Central Jutland, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-113-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.